Childhood vaccines lay the foundation for lifelong health, protecting against diseases like measles, mumps, rubella, and ...

Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have demonstrated that the NeoVax personalised cancer ...

Drs Kathryn J. Ruddy and Narjust Florez discuss fertility, pregnancy, sexual health, delays in diagnosis, and the financial burden of young-onset cancer survivorship.

PJ Branco will ride the 186-mile Pan Mass Challenge route to show support to those experiencing the same battle.

Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Early-onset colorectal cancer cases have surged globally, with incidence rates increasing in 27 of 50 countries or ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

Results of a phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax ...

Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...